Meyka Pro banner
Healthcare Realty Trust Incorporated

Stay Updated with the Latest Healthcare Realty Trust Incorporated HR News in Real Time

Find HR news now at Meyka AI. Stay informed with the latest Healthcare Realty Trust Incorporated stocks updates, including price news, market analysis, and expert insights.

HRNYSE
Real EstateREIT - Healthcare Facilities
$21.14
$0.14(0.66%)
U.S. Market opens in 15h 49m
Albanese Expands Paid Prac to 10 Health Fields, $338 Weekly Payments From July 2027
📅 in 2 minutes

Albanese Expands Paid Prac to 10 Health Fields, $338 Weekly Payments From July 2027

Australian government expands Paid Prac to 10 health professions from July 2027, providing $338.60 weekly payments to eligible students during clinical placements. Total cost $158 million over four years.

Read more 12
Former French Open Champion Rika Hiraki Arrested Over Romance Scam July 23
📅 1 hour ago

Former French Open Champion Rika Hiraki Arrested Over Romance Scam July 23

Former French Open champion Rika Hiraki arrested on suspicion of romance fraud involving 300,000 yen scam. The 54-year-old denies involvement in the scheme targeting a Kagoshima woman.

Read more 12
Secret Service Agent on Vance Detail Placed on Leave Over Leak Probe July 23
📅 3 hours ago

Secret Service Agent on Vance Detail Placed on Leave Over Leak Probe July 23

Secret Service agent on VP JD Vance’s detail placed on administrative leave after suspected leak to press about travel plans and security team complaints.

Read more 12
Dassault Systèmes (EPA: DSY) Shares Rise After Q2 Earnings Beat and Up to $2 Billion ArisGlobal AI Deal
📅 5 hours ago

Dassault Systèmes (EPA: DSY) Shares Rise After Q2 Earnings Beat and Up to $2 Billion ArisGlobal AI Deal

Dassault Systèmes reported solid Q2 2026 results on July 23, alongside a major acquisition announcement. The French software maker posted total revenue of €1.56 billion, up 4% in constant currency. Non-IFRS diluted EPS climbed 8% to €0.31, while operating margin expanded to 30%.  Dassault Systèmes also unveiled a deal to acquire life sciences software firm…

Read more 12
Indo-MIM IPO Details: Issue Size, Financial Performance, and Long-Term View
📅 8 hours ago

Indo-MIM IPO Details: Issue Size, Financial Performance, and Long-Term View

Indo-MIM opened its ₹3,811.21 crore initial public offering (IPO) on 23 July 2026, making it one of India’s largest public issues this year. The precision engineering company has drawn strong attention from both institutional and retail investors, backed by solid financial growth and a growing presence in global manufacturing markets. As India strengthens its position…

Read more 12
META Stock Drops 2.6% as Instagram Suffers Second Outage in 72 Hours
📅 9 hours ago

META Stock Drops 2.6% as Instagram Suffers Second Outage in 72 Hours

Instagram outage on July 22 left 3,700+ users unable to send messages or load profiles. Meta stock fell 2.6% as the platform suffered its second major disruption in 72 hours.

Read more 12
Australian Paid Prac Expands to 10 Health Fields, $338 Weekly Payments From July 2027
📅 17 hours ago

Australian Paid Prac Expands to 10 Health Fields, $338 Weekly Payments From July 2027

Australia expands paid practical placement payments to 10 new health professions from July 2027. Students in physiotherapy, clinical psychology, pharmacy, and others will receive $338.60 per week during unpaid clinical placements.

Read more 12
Malcolm-Jamal Warner’s Widow Sues His Mother for $1.2M Over Prenup Breach
📅 18 hours ago

Malcolm-Jamal Warner’s Widow Sues His Mother for $1.2M Over Prenup Breach

Malcolm-Jamal Warner’s widow sues his mother for $1.2 million, claiming the late actor failed to honor prenup obligations including a $1 million life insurance policy and $5,000 monthly salary.

Read more 12
Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising
📅 1 day ago

Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising

On 21 July 2026, Novo Nordisk (NYSE: NVO) filed a lawsuit against Eli Lilly (NYSE: LLY), accusing its rival of misleading consumers through advertising that compares their blockbuster GLP-1 weight-loss drugs. The legal dispute comes as demand for obesity treatments keeps rising and competition between the two drugmakers becomes more intense.  The outcome could affect…

Read more 12

HR News FAQ